BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

21551

540679

SMSLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SMS LIFESCIENCES (I) LTD performance

Today’s low

Today’s high

₹ 1296.10 ₹ 1383.90
₹ 1310.30

52 week low

52 week high

₹ 626.45 ₹ 1749.65
₹ 1310.30

Open Price

₹ 1340.60

Prev. Close

₹ 1325.20

Volume (Shares)

1821.00

Total traded value

₹ 23.86

Upper Circuit

₹ 1457.70

Lower Circuit

₹ 1192.70

info

SMS LIFESCIENCES (I) LTD Share Price Update

As of the latest trading session, SMS LIFESCIENCES (I) LTD share price is currently at ₹ 1319, which is down by ₹ -6.19 from its previous closing. Today, the stock has fluctuated between ₹ 1296.10 and ₹ 1383.90. Over the past year, SMS LIFESCIENCES (I) LTD has achieved a return of 86.30 %. In the last month alone, the return has been 17.00 %. Read More...

SMS LIFESCIENCES (I) LTD fundamentals


  • Market cap (Cr)

    398.77

  • P/E Ratio (TTM)

    16.25

  • Beta

    0.98

  • Book Value / share

    621.85

  • Return on equity

    7.68%

  • EPS (TTM)

    81.46

  • Dividend yield

    0.11%

  • Net profit/quarter (Cr)

    6.23

info icon alternate text
  • Market cap (Cr)

    398.46

  • P/E Ratio (TTM)

    16.25

  • Beta

    1.11

  • Book Value / share

    621.85

  • Return on equity

    7.68%

  • EPS (TTM)

    81.46

  • Dividend yield

    0.11%

  • Net profit/quarter (Cr)

    6.23

info icon alternate text

SMS LIFESCIENCES (I) LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 82.88
Operating Expense 74.33
Net Profit 6.23
Net Profit Margin (%) 7.51
Earnings Per Share (EPS) 20.60
EBITDA 13.13
Effective Tax Rate (%) 27.64
Particulars SEP 2024 (Values in Cr)
Revenue 78.50
Operating Expense 71.19
Net Profit 6.01
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 19.87
EBITDA 13.05
Effective Tax Rate (%) 29.78
Particulars JUN 2024 (Values in Cr)
Revenue 86.57
Operating Expense 77.46
Net Profit 6.46
Net Profit Margin (%) 7.46
Earnings Per Share (EPS) 21.37
EBITDA 14.20
Effective Tax Rate (%) 32.28
Particulars MAR 2024 (Values in Cr)
Revenue 86.37
Operating Expense 80.74
Net Profit 5.93
Net Profit Margin (%) 6.86
Earnings Per Share (EPS) 19.63
EBITDA 13.09
Effective Tax Rate (%) 24.90
Particulars DEC 2023 (Values in Cr)
Revenue 71.23
Operating Expense 66.79
Net Profit 3.31
Net Profit Margin (%) 4.64
Earnings Per Share (EPS) 10.96
EBITDA 9.66
Effective Tax Rate (%) 34.71
Particulars MAR 2024 (Values in Cr)
Revenue 300.00
Operating Expense 284.71
Net Profit 13.07
Net Profit Margin (%) 4.35
Earnings Per Share (EPS) 43.22
EBITDA 38.26
Effective Tax Rate (%) 31.65
Particulars MAR 2023 (Values in Cr)
Revenue 315.24
Operating Expense 302.09
Net Profit 13.22
Net Profit Margin (%) 4.19
Earnings Per Share (EPS) 43.72
EBITDA 31.63
Effective Tax Rate (%) 28.03
Particulars MAR 2022 (Values in Cr)
Revenue 345.63
Operating Expense 326.88
Net Profit 25.38
Net Profit Margin (%) 7.34
Earnings Per Share (EPS) 83.95
EBITDA 45.60
Effective Tax Rate (%) 23.04
Particulars MAR 2021 (Values in Cr)
Revenue 260.26
Operating Expense 242.23
Net Profit 13.17
Net Profit Margin (%) 5.06
Earnings Per Share (EPS) 43.56
EBITDA 31.06
Effective Tax Rate (%) 31.98
Particulars MAR 2020 (Values in Cr)
Revenue 256.92
Operating Expense 245.47
Net Profit 9.15
Net Profit Margin (%) 3.56
Earnings Per Share (EPS) 30.26
EBITDA 25.67
Effective Tax Rate (%) 31.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 584.84
ROE % 3.67
ROCE % 7.24
Total Debt to Total Equity 0.58
EBITDA Margin 10.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 557.71
ROE % 6.12
ROCE % 8.31
Total Debt to Total Equity 0.56
EBITDA Margin 8.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 503.53
ROE % 11.26
ROCE % 11.95
Total Debt to Total Equity 0.51
EBITDA Margin 9.31
Particulars MAR 2021 (Values in Cr)
Book Value / Share 427.40
ROE % 11.07
ROCE % 12.53
Total Debt to Total Equity 0.53
EBITDA Margin 10.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 382.80
ROE % 9.17
ROCE % 11.70
Total Debt to Total Equity 0.50
EBITDA Margin 9.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 582.90
ROE % 7.68
ROCE % 10.68
Total Debt to Total Equity 0.53
EBITDA Margin 11.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 542.55
ROE % 7.20
ROCE % 8.85
Total Debt to Total Equity 0.47
EBITDA Margin 8.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 500.16
ROE % 11.47
ROCE % 12.54
Total Debt to Total Equity 0.39
EBITDA Margin 8.67
Particulars MAR 2021 (Values in Cr)
Book Value / Share 417.88
ROE % 10.99
ROCE % 13.83
Total Debt to Total Equity 0.40
EBITDA Margin 10.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 374.61
ROE % 8.39
ROCE % 11.52
Total Debt to Total Equity 0.45
EBITDA Margin 9.09
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.49
Total Assets 390.51
Total Liabilities 390.51
Total Equity 193.63
Share Outstanding 3023287
Price to Book Ratio 1.16
Return on Assets (%) 2.32
Return on Capital (%) 3.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.41
Total Assets 394.89
Total Liabilities 394.89
Total Equity 188.21
Share Outstanding 3023287
Price to Book Ratio 0.96
Return on Assets (%) 2.90
Return on Capital (%) 4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.39
Total Assets 356.74
Total Liabilities 356.74
Total Equity 164.92
Share Outstanding 3023287
Price to Book Ratio 1.39
Return on Assets (%) 7.09
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.06
Total Assets 302.29
Total Liabilities 302.29
Total Equity 129.21
Share Outstanding 3023287
Price to Book Ratio 1.18
Return on Assets (%) 4.48
Return on Capital (%) 7.01
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.59
Total Assets 252.83
Total Liabilities 252.83
Total Equity 115.73
Share Outstanding 3023287
Price to Book Ratio 0.47
Return on Assets (%) 4.02
Return on Capital (%) 5.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 347.37
Total Liabilities 347.37
Total Equity 176.22
Share Outstanding 3023287
Price to Book Ratio 1.16
Return on Assets (%) 3.76
Return on Capital (%) 4.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.95
Total Assets 337.38
Total Liabilities 337.38
Total Equity 164.02
Share Outstanding 3023287
Price to Book Ratio 0.96
Return on Assets (%) 3.91
Return on Capital (%) 5.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.13
Total Assets 312.00
Total Liabilities 312.00
Total Equity 151.21
Share Outstanding 3023287
Price to Book Ratio 1.39
Return on Assets (%) 8.13
Return on Capital (%) 12.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.90
Total Assets 271.74
Total Liabilities 271.74
Total Equity 126.33
Share Outstanding 3023287
Price to Book Ratio 1.18
Return on Assets (%) 4.84
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.30
Total Assets 228.94
Total Liabilities 228.94
Total Equity 113.25
Share Outstanding 3023287
Price to Book Ratio 0.47
Return on Assets (%) 3.99
Return on Capital (%) 5.79
Particulars MAR 2024 (Values in Cr)
Net Income 9.84
Cash from Operations 27.30
Cash from Investing -18.45
Cash from Financing -6.56
Net change in Cash -0.70
Free Cash Flow 48.17
Particulars MAR 2023 (Values in Cr)
Net Income 14.24
Cash from Operations 17.95
Cash from Investing -31.29
Cash from Financing 16.88
Net change in Cash 0.29
Free Cash Flow 66.50
Particulars MAR 2022 (Values in Cr)
Net Income 20.03
Cash from Operations -3.53
Cash from Investing -7.14
Cash from Financing 10.83
Net change in Cash -7.55
Free Cash Flow 47.61
Particulars MAR 2021 (Values in Cr)
Net Income 19.56
Cash from Operations 40.10
Cash from Investing -26.23
Cash from Financing -2.54
Net change in Cash 6.38
Free Cash Flow 75.66
Particulars MAR 2020 (Values in Cr)
Net Income 14.66
Cash from Operations 17.60
Cash from Investing -27.01
Cash from Financing 12.44
Net change in Cash -0.02
Free Cash Flow 40.95
Particulars MAR 2024 (Values in Cr)
Net Income 19.11
Cash from Operations 17.75
Cash from Investing -13.74
Cash from Financing -0.81
Net change in Cash 0.18
Free Cash Flow 31.47
Particulars MAR 2023 (Values in Cr)
Net Income 16.02
Cash from Operations 8.07
Cash from Investing -27.96
Cash from Financing 22.59
Net change in Cash -0.79
Free Cash Flow 41.98
Particulars MAR 2022 (Values in Cr)
Net Income 20.28
Cash from Operations -7.09
Cash from Investing -7.48
Cash from Financing 14.62
Net change in Cash -7.51
Free Cash Flow 17.86
Particulars MAR 2021 (Values in Cr)
Net Income 19.35
Cash from Operations 26.22
Cash from Investing -5.94
Cash from Financing -7.86
Net change in Cash 7.80
Free Cash Flow 39.54
Particulars MAR 2020 (Values in Cr)
Net Income 13.33
Cash from Operations 16.77
Cash from Investing -13.27
Cash from Financing -2.05
Net change in Cash -1.37
Free Cash Flow 30.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

SMS LIFESCIENCES (I) LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1310.30 -1.12 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 1379.00
  • 26 Days 1295.30
  • 10 Days 1380.50
  • 50 Days 1245.20
  • 12 Days 1369.60
  • 100 Days 1222.20
  • 20 Days 1322.00
  • 200 Days 1158.30
1352.97 PIVOT

First Support

1285.93

First Resistance

1392.23

Second Support

1246.67

Second Resistance

1459.27

Third Support

1179.63

Third Resistance

1498.53

RSI

52.25

ADX

43.09

MACD

86.29

Williams % R

-54.50

Commodity Channel Index (CCI)

29.06

Date

2025-04-29

Week

1858.00

Same Day

1640.00

Month

1807.00

1 Year

0.98

3 Year

0.76

Over 1 Month

17.00%

down

Over 1 Year

86.30%

down

Over 3 Months

5.09%

down

Over 3 Years

24.85%

down

Over 6 Months

-5.33%

down

Over 5 Years

36.69%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SMS LIFESCIENCES (I) LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
28.59%
Promoter Holdings
71.4%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Annapurna Talluri 742436.0 (24.56%) Shareholding of Promoter and Promoter Group
Tvvsn Murthy 480034.0 (15.88%) Shareholding of Promoter and Promoter Group
Venkata Praveen Talluri 252752.0 (8.36%) Shareholding of Promoter and Promoter Group
Ramesh Babu Potluri 240190.0 (7.94%) Shareholding of Promoter and Promoter Group
Sudeepthi Gopineedi 199494.0 (6.6%) Shareholding of Promoter and Promoter Group
Hima Bindu Potluri 83333.0 (2.76%) Shareholding of Promoter and Promoter Group
Trilok Potluri 78141.0 (2.58%) Shareholding of Promoter and Promoter Group
Vamsi Krishna Potluri 73234.0 (2.42%) Shareholding of Promoter and Promoter Group
Harita Projects Private 47508.0 (1.57%) Public Shareholding
Bharadhwajan Jaganathan Velamur 31150.0 (1.03%) Public Shareholding
Potluri Infra Projects Llp 8000.0 (0.26%) Shareholding of Promoter and Promoter Group
Sukumari Koneru 714.0 (0.02%) Shareholding of Promoter and Promoter Group
Venkata Chaitanya Gopineedi 361.0 (0.01%) Shareholding of Promoter and Promoter Group
Pixalot Labs Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Potluri Laboratories Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajeswara Rao Gopineedi 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Tvvsn Murthy (huf) (karta - Mr.tvvsn Murthy) 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SMS LIFESCIENCES (I) LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.5 Final 23 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 24 Sep 2022 Equity shares
20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.5 Final 23 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 24 Sep 2022 Equity shares
20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SMS LIFESCIENCES (I) LTD Share Price

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006. The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016.

The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98.

Having three multi product facilities in operation and a research centre, the Company executed contract manufacturing and research assignment for global customer base. The Scheme of Arrangement between SMS Pharmaceuticals Limited with the Company was implemented in 2016-17. Pursuant to the Scheme, the Semi Regulated facilities i.e Unit No. I, IV and V along with premises situated at Industrial Estate, Sanathnagar, Hyderabad; Industrial Development Area, Jeedimetla, Hyderabad; Premises bearing Flat No.417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad; vacant land admeasuring Ac 19.00 cents situated at Pharma City, Parawada, Visakhapatnam and Investments relating to Semi Regulated Units of SMS Pharmaceuticals Limited got demerged into the Company and the said Scheme of Demerger was given effect on May 17, 2017. The Company allotted 30,23,287 Equity Shares of Rs. 10 each to the shareholders of SMS Pharmaceuticals Limited on 27 June, 2017 in pursuance of Demerger Scheme.

The Company made Mahi Drugs Private Limited as a wholly owned subsidiary of the Company in 2017-18. by acquiring 9,00,000 Equity Shares effective on 17th September, 2018. Similarly, the Company diluted its 10% stake in Mahi Drugs Private Limited during the period 2021-22 and it ceased to be a wholly-owned subsidiary of the Company w.e.f. 7th February, 2022.

Parent organization Indian Private
NSE symbol SMSLIFE
Founded 2006
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of SMS Lifesciences India Ltd?

Answer Field

The share price of SMS Lifesciences India Ltd for NSE is ₹ 1319 and for BSE is ₹ 1318.

What is the Market Cap of SMS Lifesciences India Ltd?

Answer Field

The market cap of SMS Lifesciences India Ltd for NSE is ₹ 3,98.77 Cr. and for BSE is ₹ 3,98.46 Cr. as of now.

What is the 52 Week High and Low of SMS Lifesciences India Ltd?

Answer Field

The 52 Week High and Low of SMS Lifesciences India Ltd for NSE is ₹ 1749.65 and ₹ 626.45 and for BSE is ₹ 1747.85 and ₹ 630.75.

How to Buy SMS Lifesciences India Ltd share?

Answer Field

You can trade in SMS Lifesciences India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for SMS Lifesciences India Ltd?

Answer Field

The 1 year returns on the stock has been 88.51%.

What is the Current Share Price of SMS Lifesciences India Ltd?

Answer Field

SMS Lifesciences India Ltd share price is for NSE ₹ 1319 & for BSE ₹ 1318 as on Apr 30 2025 03:29 PM.

What is the Market Cap of SMS Lifesciences India Ltd Share?

Answer Field

The market cap of SMS Lifesciences India Ltd for NSE ₹ 3,98.77 & for BSE ₹ 3,98.46 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of SMS Lifesciences India Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for SMS Lifesciences India Ltd share is 16.25.

What is the PB ratio of SMS Lifesciences India Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for SMS Lifesciences India Ltd share is 621.85.

How to Buy SMS Lifesciences India Ltd Share?

Answer Field

You can trade in SMS Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy SMS Lifesciences India Ltd Share on Bajaj Broking App?

Answer Field

To buy SMS Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “SMS Lifesciences India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|